Amp Capital Investors LTD Innoviva, Inc. Transaction History

Amp Capital Investors LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $438,918 - $582,932	-38,200 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$10.28 - $14.38 $68,876 - $96,346	6,700 Added 21.27%	38,200 $542,000
Q3 2019 Nov 13, 2019	SELL	$10.05 - $14.55 $116,781 - $169,071	-11,620 Reduced 26.95%	31,500 $325,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $275,100 - $313,950	21,000 Added 94.94%	43,120 $614,000
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $302,822 - $443,727	22,120 New	22,120 $309,000
Q3 2018 Nov 13, 2018	SELL	$13.63 - $15.7 $271,686 - $312,948	-19,933 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$13.44 - $17.59 $127,760 - $167,210	9,506 Added 91.17%	19,933 $275,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $143,892 - $177,154	10,427 New	10,427 $175,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.